• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    69.51 Up 0.55(0.80%) 4:00PM EST
    |After Hours : 69.51 0.00 (0.00%) 4:40PM EST
    Add to Portfolio
    Prev Close:68.96
    Open:68.89
    Bid:60.03 x 300
    Ask:79.95 x 100
    1y Target Est:89.40
    Beta:1.4
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:68.27 - 70.62
    52wk Range:41.99 - 80.21
    Volume:231,244
    Avg Vol (3m):296,700
    Market Cap:1.36B
    P/E (ttm):124.13
    EPS (ttm):0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDUp 0.80%1.36B
    LLYDown 3.09%72.56B
    MRKDown 1.97%161.32B
    RHHBYUp 0.47%N/A

    Key Statistics

    Forward P/E (1 yr):21.00
    P/S (ttm):20.92
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.17
    Quarterly EPS Est (Mar-15) :0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback